LEGN
Price:
$48.29
Market Cap:
$9.90B
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candid...[Read more]
Industry
Biotechnology
IPO Date
2020-06-05
Stock Exchange
NASDAQ
Ticker
LEGN
According to Legend Biotech Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -34.99. This represents a change of -38.33% compared to the average of -56.74 of the last 4 quarters.
The mean historical PE Ratio of Legend Biotech Corporation over the last ten years is -130.06. The current -34.99 PE Ratio has changed 2.59% with respect to the historical average. Over the past ten years (40 quarters), LEGN's PE Ratio was at its highest in in the June 2020 quarter at -8.49. The PE Ratio was at its lowest in in the June 2024 quarter at -115.46.
Average
-130.06
Median
-17.79
Minimum
-1329.02
Maximum
521.54
Discovering the peaks and valleys of Legend Biotech Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 55.05%
Maximum Annual PE Ratio = 521.54
Minimum Annual Increase = -354.83%
Minimum Annual PE Ratio = -1329.02
Year | PE Ratio | Change |
---|---|---|
2023 | -20.44 | 14.93% |
2022 | -17.79 | 4.64% |
2021 | -17.00 | 55.05% |
2020 | -10.96 | -70.15% |
2019 | -36.73 | -97.24% |
2018 | -1329.02 | -354.83% |
The current PE Ratio of Legend Biotech Corporation (LEGN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-18.41
5-year avg
-20.58
10-year avg
-130.06
Legend Biotech Corporation’s PE Ratio is less than Vaxcyte, Inc. (-26.31), less than Apellis Pharmaceuticals, Inc. (-15.28), less than Travere Therapeutics, Inc. (-5.83), less than Akero Therapeutics, Inc. (-8.95), less than IVERIC bio, Inc. (-33.43), less than Blueprint Medicines Corporation (-26.44), less than Amylyx Pharmaceuticals, Inc. (-0.97), less than Karuna Therapeutics, Inc. (-29.52), less than Day One Biopharmaceuticals, Inc. (-7.39), less than Zai Lab Limited (-6.49), greater than Seagen Inc. (-57.36), greater than Alnylam Pharmaceuticals, Inc. (-428.77), less than Ascendis Pharma A/S (-12.57), less than 89bio, Inc. (-4.84), less than Madrigal Pharmaceuticals, Inc. (-10.23), less than Pliant Therapeutics, Inc. (-4.19), greater than Arcellx, Inc. (-70.75), less than Stoke Therapeutics, Inc. (-7.92), less than Mirati Therapeutics, Inc. (-5.32), less than Terns Pharmaceuticals, Inc. (-6.06),
Company | PE Ratio | Market cap |
---|---|---|
-26.31 | $12.45B | |
-15.28 | $5.00B | |
-5.83 | $839.88M | |
-8.95 | $1.83B | |
-33.43 | $5.51B | |
-26.44 | $5.47B | |
-0.97 | $161.36M | |
-29.52 | $12.60B | |
-7.39 | $1.25B | |
-6.49 | $1.97B | |
-57.36 | $43.15B | |
-428.77 | $31.68B | |
-12.57 | $6.83B | |
-4.84 | $897.06M | |
-10.23 | $5.30B | |
-4.19 | $782.51M | |
-70.75 | $3.83B | |
-7.92 | $773.92M | |
-5.32 | $4.12B | |
-6.06 | $549.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Legend Biotech Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Legend Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Legend Biotech Corporation's PE Ratio?
How is the PE Ratio calculated for Legend Biotech Corporation (LEGN)?
What is the highest PE Ratio for Legend Biotech Corporation (LEGN)?
What is the 3-year average PE Ratio for Legend Biotech Corporation (LEGN)?
What is the 5-year average PE Ratio for Legend Biotech Corporation (LEGN)?
How does the current PE Ratio for Legend Biotech Corporation (LEGN) compare to its historical average?